BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29247263)

  • 1. Pretreatment identification of patients likely to have pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancer.
    van der Sluis FJ; van Westreenen HL; van Etten B; van Leeuwen BL; de Bock GH
    Int J Colorectal Dis; 2018 Feb; 33(2):149-157. PubMed ID: 29247263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical tumour size and nodal status predict pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer.
    Garland ML; Vather R; Bunkley N; Pearse M; Bissett IP
    Int J Colorectal Dis; 2014 Mar; 29(3):301-7. PubMed ID: 24420737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation.
    Probst CP; Becerra AZ; Aquina CT; Tejani MA; Wexner SD; Garcia-Aguilar J; Remzi FH; Dietz DW; Monson JR; Fleming FJ;
    J Am Coll Surg; 2015 Aug; 221(2):430-40. PubMed ID: 26206642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
    Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
    Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.
    Al-Sukhni E; Attwood K; Mattson DM; Gabriel E; Nurkin SJ
    Ann Surg Oncol; 2016 Apr; 23(4):1177-86. PubMed ID: 26668083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodal Disease in Rectal Cancer Patients With Complete Tumor Response After Neoadjuvant Chemoradiation: Danger Below Calm Waters.
    Baucom RB; Maguire LH; Kavalukas SL; Geiger TM; Ford MM; Muldoon RL; Hopkins MB; Hawkins AT
    Dis Colon Rectum; 2017 Dec; 60(12):1260-1266. PubMed ID: 29112561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inferior mesenteric artery lymph node metastasis in rectal cancer treated with neoadjuvant chemoradiotherapy: Incidence, prediction and prognostic impact.
    Sun Y; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Wang X
    Eur J Surg Oncol; 2017 Jan; 43(1):85-91. PubMed ID: 27717528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation.
    Shahab D; Gabriel E; Attwood K; Ma WW; Francescutti V; Nurkin S; Boland PM
    Clin Colorectal Cancer; 2017 Dec; 16(4):300-307. PubMed ID: 28420585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Reggiani Bonetti L; Lionti S; Domati F; Pagliani G; Mattioli E; Barresi V
    Histopathology; 2017 Sep; 71(3):393-405. PubMed ID: 28425130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-level step section histological analysis is insufficient to confirm complete pathological response after neoadjuvant chemoradiation for rectal cancer.
    Pereira MA; Dias AR; Faraj SF; Nahas CSR; Imperiale AR; Marques CFS; Cotti GC; Azevedo BC; Nahas SC; de Mello ES; Ribeiro U
    Tech Coloproctol; 2017 Sep; 21(9):745-754. PubMed ID: 28819868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
    Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
    Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
    Newton AD; Li J; Jeganathan AN; Mahmoud NN; Epstein AJ; Paulson EC
    Dis Colon Rectum; 2016 Aug; 59(8):710-7. PubMed ID: 27384088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nomogram to predict distant metastasis after neoadjuvant chemoradiotherapy and radical surgery in patients with locally advanced rectal cancer.
    Sun Y; Lin H; Lu X; Huang Y; Xu Z; Huang S; Wang X; Chi P
    J Surg Oncol; 2017 Mar; 115(4):462-469. PubMed ID: 28105657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single institution's long-term follow-up of patients with pathological complete response in locally advanced rectal adenocarcinoma following neoadjuvant chemoradiotherapy.
    Runau F; Collins A; Fenech GA; Ford E; Dimitriou N; Chaudhri S; Yeung JM
    Int J Colorectal Dis; 2017 Mar; 32(3):341-348. PubMed ID: 27885480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictive factors associated with pathologic complete response after neoadjuvant chemoradiotherapy in rectal cancer].
    Sun Y; Chi P; Xu B; Lin H; Lu X; Huang Y; Xu Z; Huang S; Jiang C
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jun; 17(6):556-60. PubMed ID: 24953361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
    Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
    Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.
    Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I
    Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer?
    São Julião GP; Habr-Gama A; Vailati BB; Aguilar PB; Sabbaga J; Araújo SEA; Mattacheo A; Alexandre FA; Fernandez LM; Gomes DB; Gama-Rodrigues J; Perez RO
    Eur J Surg Oncol; 2018 Jan; 44(1):93-99. PubMed ID: 29217398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does pathologic response of rectal cancer influence postoperative morbidity after neoadjuvant radiochemotherapy and total mesorectal excision?
    Maggiori L; Bretagnol F; Aslam MI; Guedj N; Zappa M; Ferron M; Panis Y
    Surgery; 2014 Mar; 155(3):468-75. PubMed ID: 24439750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer.
    Mace AG; Gantt GA; Skacel M; Pai R; Hammel JP; Kalady MF
    Dis Colon Rectum; 2013 Nov; 56(11):1217-27. PubMed ID: 24104995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.